InvestorsHub Logo
Followers 6
Posts 923
Boards Moderated 0
Alias Born 09/28/2012

Re: jamtomorrow2 post# 4679

Sunday, 08/21/2016 5:47:03 PM

Sunday, August 21, 2016 5:47:03 PM

Post# of 9136
I guess this is one of the reasons the stock has not performed well lately. And yet bococizumab is still in the pipeline on the halo website.

Does anybody know what's happening with the Humira trial? I have a vague memory that phase 1 was supposed to end in July.

We really need some meaningful good news to move the stock.

I agree that Halo would become profitable if PEGPH20 failed but they only added 900K in royalties from Q1 to Q2. If royalties don't start growing faster or some of the partnerships trials move to phase 2 soon, I'm not sure the upside would be that significant from where the stock is now without success with PEGPH20.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News